The Gross Margin of Sino Biopharmaceutical Ltd (1177.HK) is 81.51%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 81.51% |
| 2023-12-31 | 80.95% |
| 2022-12-31 | 84.41% |
| 2021-12-31 | 80.15% |
| 2020-12-31 | 78.08% |
| 2019-12-31 | 79.67% |
| 2018-12-31 | 79.91% |
| 2017-12-31 | 79.14% |
| 2016-12-31 | 79.20% |
| 2015-12-31 | 77.67% |